Should a pregnant patient with a positive urine culture for Staphylococcus epidermidis, 10-15 leukocytes per high power field (HPF), and 60,000 Colony-Forming Units (CFU) be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No debe tratarse este urocultivo en embarazadas

Este resultado de urocultivo con Staphylococcus epidermidis a 60,000 UFC/mL NO cumple los criterios microbiológicos para bacteriuria asintomática significativa y NO requiere tratamiento antibiótico.

Criterios Diagnósticos para Bacteriuria Asintomática en Embarazo

  • La bacteriuria asintomática significativa se define como ≥10^5 UFC/mL (100,000 UFC/mL) de un único uropatógeno en una muestra de orina de chorro medio 1
  • El recuento de 60,000 UFC/mL está por debajo del umbral diagnóstico establecido y no justifica tratamiento 1
  • S. epidermidis es un estafilococo coagulasa-negativo que coloniza la piel y frecuentemente contamina las muestras de orina, especialmente en mujeres 2

Por Qué Este Resultado No Requiere Tratamiento

  • Recuento insuficiente: 60,000 UFC/mL no alcanza el criterio de ≥100,000 UFC/mL necesario para diagnosticar bacteriuria asintomática verdadera 1
  • Organismo no patógeno: S. epidermidis no es un uropatógeno típico y su presencia generalmente representa contaminación cutánea durante la recolección 2
  • Piuria leve: 10-15 leucocitos por campo puede ser un hallazgo inespecífico y no confirma infección cuando el recuento bacteriano es bajo 3

Cuándo SÍ Está Indicado el Tratamiento en Embarazo

  • Uropatógenos verdaderos a ≥100,000 UFC/mL: E. coli, Klebsiella, Proteus, Enterococcus 4
  • Streptococcus agalactiae (Estreptococo del Grupo B) en orina a CUALQUIER concentración (incluso <10^3 UFC/mL) requiere tratamiento inmediato y profilaxis intraparto 1
  • Bacteriuria sintomática con disuria, frecuencia urinaria, urgencia o dolor suprapúbico 3, 5

Riesgos de Tratar Innecesariamente

  • Efectos adversos de antibióticos en la madre y el feto 1
  • Desarrollo de resistencia bacteriana, problema creciente en embarazadas 2, 6
  • Alteración de la flora vaginal normal que puede predisponer a otras infecciones 6

Algoritmo de Manejo

  1. Verificar el recuento de colonias: Si <100,000 UFC/mL → NO tratar 1
  2. Identificar el organismo:
    • Si es S. epidermidis u otro estafilococo coagulasa-negativo → considerar contaminación, NO tratar 2
    • Si es Estreptococo del Grupo B → tratar inmediatamente independientemente del recuento 1
    • Si es E. coli, Klebsiella, u otro uropatógeno verdadero a ≥100,000 UFC/mL → tratar 4, 7
  3. Evaluar síntomas: Si la paciente tiene síntomas de cistitis o pielonefritis, considerar repetir el urocultivo con técnica estéril 3, 5

Errores Comunes a Evitar

  • No tratar recuentos bacterianos <100,000 UFC/mL de organismos no patógenos como si fueran infecciones verdaderas 1
  • Confundir S. epidermidis (contaminante común) con Estreptococo del Grupo B (que requiere tratamiento a cualquier concentración) 1, 2
  • Ignorar que la piuria leve sin bacteriuria significativa no justifica antibióticos 3
  • Olvidar que el tamizaje de bacteriuria asintomática en embarazo está diseñado para detectar uropatógenos verdaderos, no flora normal o contaminantes 1, 4

Recomendación de Seguimiento

  • Si la paciente permanece asintomática, no se requiere tratamiento ni repetición del cultivo 1
  • Continuar con el tamizaje rutinario de bacteriuria asintomática a las 12-16 semanas de gestación si aún no se ha realizado 1
  • Si desarrolla síntomas urinarios, obtener nuevo urocultivo con técnica de recolección cuidadosa para minimizar contaminación 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Positive Lactobacillus Urine Culture in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urinary tract infections in pregnancy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023

Guideline

Antibiotic Treatment for Kidney Infection Caused by E. coli in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the immediate recommendations for a 7-week pregnant patient experiencing dark brown urine and light spotting?
What is the appropriate management for a pregnant lady with vaginal odor, microscopic hematuria, and pyuria, but a negative urine culture, who was started on amoxicillin for a suspected urinary tract infection (UTI)?
What is the recommended treatment for an asymptomatic 28-week pregnant woman with a urine culture showing 10,000-49,000 Colony-Forming Units per milliliter (CFU/mL) of Coagulase-negative staphylococcus?
Do I need to order antibiotics for a 6-week pregnant patient with bacteriuria (presence of bacteria in urine) in the Urinalysis (UA) and a negative Urine Culture?
Does a urine culture result of 50,000 colony forming units (CFU) indicate a urinary tract infection (UTI)?
What is the best approach to managing vomiting in pediatric patients?
What are the recommendations for hormone replacement therapy (HRT) in a postmenopausal woman with hypertension?
What is the mechanism of action and dosage of benzenoids when used in combination with Proton Pump Inhibitors (PPIs), such as omeprazole (Prilosec), for patients with conditions like Gastroesophageal Reflux Disease (GERD) or Peptic Ulcer Disease, considering factors like Impaired Renal Function?
What is the best time of day for an adult patient with hypertension to take nebivolol (beta blocker)?
What is the treatment for Tullio phenomenon?
Where is the inflammation typically located in a patient with gout in the knees?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.